In cross-sectional analyses, the present results showed higher levels of VILIP-1 in individuals with MCI and AD compared with cognitively normal individuals; however, this difference did not reach statistical significance in contrast to prior publications [ 17 , 25 , 27 , 42 , 43 ].
← all excerpts
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
1
—
—